dihydroxyphenylalanine has been researched along with technetium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kung, HF | 1 |
| Cascini, GL; Cuccurullo, V; Mansi, L; Rotondo, A; Tamburrini, O | 1 |
| Acevedo-Báñez, I; Álvarez-Pérez, RM; Borrego-Dorado, I; Cuenca-Cuenca, JI; García-Gómez, FJ; García-Jiménez, R; García-Morillo, JS; Martínez-Castillo, R; Pachón-Garrudo, VM; Rivas-Infante, E; Tirado-Hospital, JL | 1 |
2 review(s) available for dihydroxyphenylalanine and technetium
| Article | Year |
|---|---|
Overview of radiopharmaceuticals for diagnosis of central nervous disorders.
Topics: Brain Diseases; Dihydroxyphenylalanine; Glucose; Humans; Perfusion; Receptors, Dopamine; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1991 |
Bone metastases radiopharmaceuticals: an overview.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Sodium Fluoride; Somatostatin; Technetium; Thymidine; Tomography, Emission-Computed, Single-Photon | 2013 |
1 other study(ies) available for dihydroxyphenylalanine and technetium
| Article | Year |
|---|---|
The role of 18FDG, 18FDOPA PET/CT and 99mTc bone scintigraphy imaging in Erdheim-Chester disease.
Topics: Adult; Aged; Bone and Bones; Dihydroxyphenylalanine; Erdheim-Chester Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium; Tomography, X-Ray Computed | 2015 |